Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $111B |
| FY2017, ended Dec 31, 2017 | $159B |
| FY2018, ended Dec 31, 2018 | $194B |
| FY2019, ended Dec 31, 2019 | $300B |
| FY2020, ended Dec 31, 2020 | $355B |
| FY2021, ended Dec 31, 2021 | $351B |
| FY2022, ended Dec 31, 2022 | $331B |
| FY2023, ended Dec 31, 2023 | $398B |
| FY2024, ended Dec 31, 2024 | $480B |
| FY2025, ended Dec 31, 2025 | $509B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $450B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.8B |
| FY2017, ended Dec 31, 2017 | $12.5B |
| FY2018, ended Dec 31, 2018 | $21.8B |
| FY2019, ended Dec 31, 2019 | $25.0B |
| FY2020, ended Dec 31, 2020 | $23.6B |
| FY2021, ended Dec 31, 2021 | $29.8B |
| FY2022, ended Dec 31, 2022 | $22.2B |
| FY2023, ended Dec 31, 2023 | $25.1B |
| FY2024, ended Dec 31, 2024 | $28.2B |
| FY2025, ended Dec 31, 2025 | $32.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $35.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.06B | $4.42B |
| FY2017, ended Dec 31, 2017 | $3.92B | $5.36B |
| FY2018, ended Dec 31, 2018 | $5.86B | $5.89B |
| FY2019, ended Dec 31, 2019 | $8.12B | $7.76B |
| FY2020, ended Dec 31, 2020 | $6.41B | $6.88B |
| FY2021, ended Dec 31, 2021 | $8.69B | $9.06B |
| FY2022, ended Dec 31, 2022 | $9.93B | $10.8B |
| FY2023, ended Dec 31, 2023 | $11.2B | $11.6B |
| FY2024, ended Dec 31, 2024 | $12.9B | $14.3B |
| FY2025, ended Dec 31, 2025 | $15.0B | $17.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $16.3B | $16.7B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.72B |
| FY2017, ended Dec 31, 2017 | $5.93B |
| FY2018, ended Dec 31, 2018 | $6.68B |
| FY2019, ended Dec 31, 2019 | $6.99B |
| FY2020, ended Dec 31, 2020 | $10.1B |
| FY2021, ended Dec 31, 2021 | $7.42B |
| FY2022, ended Dec 31, 2022 | $7.01B |
| FY2023, ended Dec 31, 2023 | $8.59B |
| FY2024, ended Dec 31, 2024 | $8.44B |
| FY2025, ended Dec 31, 2025 | $10.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $11.3B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.18B |
| FY2017, ended Dec 31, 2017 | $5.42B |
| FY2018, ended Dec 31, 2018 | $6.33B |
| FY2019, ended Dec 31, 2019 | $8.53B |
| FY2020, ended Dec 31, 2020 | $12.7B |
| FY2021, ended Dec 31, 2021 | $13.9B |
| FY2022, ended Dec 31, 2022 | $14.0B |
| FY2023, ended Dec 31, 2023 | $15.7B |
| FY2024, ended Dec 31, 2024 | $18.2B |
| FY2025, ended Dec 31, 2025 | $19.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $24.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 18.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.08B |
| FY2017, ended Dec 31, 2017 | 1.05B |
| FY2018, ended Dec 31, 2018 | 1.03B |
| FY2019, ended Dec 31, 2019 | 1.01B |
| FY2020, ended Dec 31, 2020 | 993M |
| FY2021, ended Dec 31, 2021 | 977M |
| FY2022, ended Dec 31, 2022 | 953M |
| FY2023, ended Dec 31, 2023 | 933M |
| FY2024, ended Dec 31, 2024 | 912M |
| FY2025, ended Dec 31, 2025 | 892M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 876M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.51B | $149M |
| FY2017, ended Dec 31, 2017 | $3.76B | $176M |
| FY2018, ended Dec 31, 2018 | $4.93B | $196M |
| FY2019, ended Dec 31, 2019 | $6.50B | $250M |
| FY2020, ended Dec 31, 2020 | $4.47B | $254M |
| FY2021, ended Dec 31, 2021 | $5.90B | $273M |
| FY2022, ended Dec 31, 2022 | $8.75B | $295M |
| FY2023, ended Dec 31, 2023 | $9.03B | $460M |
| FY2024, ended Dec 31, 2024 | $11.0B | $526M |
| FY2025, ended Dec 31, 2025 | $11.7B | $597M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $15.8B | $615M |
Valuation
At current price- Market Cap
- $534B
- P/E
- 32.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 15.2×
- Price / Book
- 95.2×
- EV / EBITDA
- 25.3×
Growth
Trailing 12 months- Revenue (TTM)
- $35.1B
- Revenue Growth YoY
- 16.0%
- Revenue CAGR 3Y
- 13.8%
- Revenue CAGR 5Y
- 6.8%
- EPS Growth YoY
- 22.6%
- Net Income Growth YoY
- 19.7%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 58.3%
- Net Margin
- 46.3%
- FCF Margin
- 47.6%
- Return on Equity
- 241%
Earnings
Trailing 12 months- Net Income
- $16.3B
- EPS (diluted)
- $18.18
- EBITDA
- $21.7B
- Operating Income
- $20.5B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $11.3B
- Total Debt
- $24.6B
- Net Debt
- $13.4B
- Total Assets
- $57.7B
- Total Liabilities
- $52.1B
- Shareholders' Equity
- $5.61B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $17.4B
- Capital Expenditure
- $735M
- Free Cash Flow
- $16.7B
Dividends and risk
Last 12 months- Dividend Yield
- 0.6%
- Dividend / Share
- $3.48
- Beta (5Y)
- 0.76
Every ratio is calculated from the company’s reported figures.